These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6755677)

  • 1. Prednisolone in renal transplantation: a comparison between two dosage regimes.
    Bergrem H; Jakobsen A; Flatmark A
    Scand J Urol Nephrol Suppl; 1981; 64():174-8. PubMed ID: 6755677
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose steroids in renal transplantation: one year experience in Uppsala.
    Fjellström KE; Andreen T; Frödin L; Odlind B; Weiss L
    Scand J Urol Nephrol Suppl; 1981; 64():185-90. PubMed ID: 6755678
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of two different immunosuppressive dosages of methylprednisolone in clinical renal transplantation.
    Eklund B; Ahonen J; Häyry P; Kauste A; von Willebrand E; Lindström BL
    Scand J Urol Nephrol Suppl; 1981; 64():179-84. PubMed ID: 6815790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on patient and graft survival of reducing the methylprednisolone dose after renal transplantation.
    Kuhlbäck B
    Scand J Urol Nephrol Suppl; 1981; 64():191-4. PubMed ID: 6755679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced steroid doses in cadaveric renal transplantation.
    Ost L; Collste H; Lundgren G; Magnusson G; Ringdén O; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():195-9. PubMed ID: 6755680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonsteroid treatment of rejection in kidney transplantation. A new approach including long-term treatment of rejection with antilymphoblast globulin in a high risk population.
    Toledo-Pereyra LH; Mittal VK; Baskin S; McNichol LJ; Whitten JI
    Transplantation; 1982 Mar; 33(3):325-7. PubMed ID: 6801834
    [No Abstract]   [Full Text] [Related]  

  • 8. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 9. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 10. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 11. To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival.
    Ahn MS; Ha J; Yun IJ; Kim S; Lee JS; Kim S; Han JS; Ahn C; Choi Y; Cheong HI; Kim ST; Kim SJ
    Transplant Proc; 1996 Jun; 28(3):1316-7. PubMed ID: 8658675
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of 2200 kidney transplantations].
    Tang Y; Zhang Y; Jia B
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(2):82-5. PubMed ID: 11798855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of hospital admission following successful renal transplantation.
    Kim HC; Joo I; Kwon JK; Suk J; Park SB
    Transplant Proc; 1996 Jun; 28(3):1603. PubMed ID: 8658803
    [No Abstract]   [Full Text] [Related]  

  • 15. OKT3 in renal allografts: survival and complications.
    D'Souza RJ; Kwan JT; Chang R; Bending MR
    Clin Nephrol; 1999 Apr; 51(4):257-8. PubMed ID: 10230561
    [No Abstract]   [Full Text] [Related]  

  • 16. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved results in high risk cadaveric kidney transplantation.
    Toledo-Pereyra LH; Baskin S; McNichol L; Edford G; Whitten J; Allaben R
    Proc Clin Dial Transplant Forum; 1980; 10():289-92. PubMed ID: 7050990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
    Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.